Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Go back to Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Guardant Health (GH) PT Raised to $100 at BofA Securities

October 30, 2025 7:59 AM EDT

BofA Securities analyst Derik de Bruin raised the price target on Guardant Health (NASDAQ: GH) to $100.00 (from $65.00) while maintaining a Buy rating.

... More